Future work in GEMMs of advanced LUAD progression such as the LSL-KrasG12D/+; p53flox/flox model will reveal whether the glutathione and thioredoxin systems play a role in Nrf2-mediated adenocarcinoma suppression. This evidence concerns the gene TXN and adenocarcinoma.